Hanmi Pharma

Bio & Pharma Samsung Biologics bags $514 mn CMO contract from US pharma

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...

Electronics Hanmi Semiconductor to retire $90 mn treasury shares in May

Hanmi Semiconductor Co. on Thursday announced a plan to retire 130.0 billion won ($90 million) worth of treasury shares in May, marking its largest-...

Bio & Pharma Samsung Biologics signs $1.4 bn CMO deal with European pharma

South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...

Electronics Hanmi Semiconductor to build new TC Bonder plant in Incheon

Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, held a ground-breaking ceremony for its seventh plant of...

Corporate governance Hanmi Pharm’s chair poised to win management feud with her son

Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...

Bio & Pharma Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

Bio & Pharma Hanmi breaks ground pharmaceuticals complex in Beijing

South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...

Private equity La Defense might have a say over Hanmi Pharm's family feud

La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Bio & Pharma Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

Bio & Pharma Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Banking & Finance Hanmi Bank rises from Koreatown lender to regional bank

It began in 1982 as a small community bank for Korean immigrants in Los Angeles, California. Today, Hanmi Bank, under Nasdaq-listed Hanmi Financial ...

Pension funds NPS signals more say in Hanmi Pharmaceutical's family feud

South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...

Bio & Pharma IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

Corporate governance Korea’s Hanmi family feud to end as key shareholder mediates

South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...

Korean chipmakers Hanmi Semiconductor eyes $1.5 billion sales in 2026

Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, has revised upwards its annual sales target for this yea...

Bio & Pharma Kwangdong Pharma acquires stake in Precision Bio

South Korea's Kwangdong Pharmaceutical announced on Tuesday that it signed a stock purchase agreement to acquire Precision Biosensor Inc., a company...

Korean chipmakers Booming AI industry boosts chip packaging equipment makers

Global chip packaging equipment manufacturers are enjoying surging demand and skyrocketing share prices thanks to the rapid growth of the artificial...

Korean chipmakers Hanmi Semiconductor wins $110 mn HBM equipment order from SK Hynix

South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has received an order from SK Hynix Inc. for its dual TC bon...

Bio & Pharma Samsung Biologics eyes windfall gain amid US-China row

SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...

Corporate governance Hanmi to fire founder's wife, entering new round of family feud

South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...

Bio & Pharma HK inno.N to release K-CAB in MENA market

South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...

Bio & Pharma KKR, Hanmi heirs likely to join hands for controlling stake

The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...

Mergers & Acquisitions Hanmi’s planned merger with OCI scrapped as sons win family feud

Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...

Corporate governance Hanmi Science-OCI merger may gain traction with NPS' support

The merger of South Korea’s pharmaceutical holding firm Hanmi Science Co. and chemicals giant OCI Holdings Co. is likely to gain momentum as N...

Korean chipmakers Hanmi Semiconductor wins $16 mn HBM equipment order from SK Hynix

South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has secured a 21.5 billion won ($16.1 million) supply deal f...

Mergers & Acquisitions Proxy advisor KCGS backs Hanmi founder's sons return to board

South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...

Logistics Samsung SDS gets CEIV Pharma certification

South Korea's Samsung SDS Co. said on Wednesday that it has achieved the Center of Excellence for Independent Validators in Pharmaceutical Logistics...

Mergers & Acquisitions OCI-Hanmi merger faces tougher hurdles amid family feud

Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...

Mergers & Acquisitions OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...